A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Clinical trial NCT02963077 · COMPLETED

Trial details

NCT number: NCT02963077
Sponsor: Albireo
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Orphan Cholestatic Liver Diseases Primary Biliary Cirrhosis Progressive Familial Intrahepatic Cholestasis Alagille Syndrome

Start date: 2013-07-01
Primary completion: 2014-05-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.